Skip to main content

We narrowed to 21,505 results for: omp

Showing: 1801 - 1820 of 21505 results
  1. TLNRD1(4H)-2T_pET47b

    Plasmid
    #224069
    Purpose
    Bacterial expression of the 4-helix bundle of TLNRD1 (residues 143-273) containing the mutations L191T/A225T, fused to an N-terminal hexa-histidine tag. HRV-3C cleavage site
    Depositor
    Insert
    tlnrd1 (TLNRD1 Human)
    Tags
    6xHIS
    Expression
    Bacterial
    Mutation
    L191T/A225T double mutant; reduces affinity of TL…
    Promoter
    T7
    Available Since
    Aug. 26, 2024
    Availability
    Industry, Academic Institutions, and Nonprofits
  2. TLNRD1(4H)-2E_pET151

    Plasmid
    #224068
    Purpose
    Bacterial expression of the 4-helix bundle of TLNRD1 (residues 143-273) containing the mutations K192E/R233E, fused to an N-terminal hexa-histidine tag. TEV cleavage site
    Depositor
    Insert
    tlnrd1 (TLNRD1 Human)
    Tags
    6xHIS; V5
    Expression
    Bacterial
    Mutation
    K192E/R233E double mutant; prevents actin binding…
    Promoter
    T7
    Available Since
    Aug. 26, 2024
    Availability
    Industry, Academic Institutions, and Nonprofits
  3. pGP-AAV-syn-FLEX-jGCaMP7c variant 1513-WPRE (AAV1)

    Viral Prep
    #105322-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pGP-AAV-syn-FLEX-jGCaMP7c variant 1513-WPRE (#105322). In addition to the viral particles, you will also receive purified pGP-AAV-syn-FLEX-jGCaMP7c variant 1513-WPRE plasmid DNA. Synapsin-driven, Cre-dependent jGCaMP7c expression. jGCaMP7c exhibits high contrast between peak fluorescence and resting fluorescence. It is useful for activity imaging of large populations of densely-labeled neurons because background fluorescence from inactive neurons is reduced. These AAV preparations are suitable purity for injection into animals.
    Promoter
    Syn
    Available Since
    June 13, 2019
    Availability
    Academic Institutions and Nonprofits only
  4. pGP-AAV-syn-jGCaMP7c variant 1513-WPRE (AAV1)

    Viral Prep
    #105321-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pGP-AAV-syn-jGCaMP7c variant 1513-WPRE (#105321). In addition to the viral particles, you will also receive purified pGP-AAV-syn-jGCaMP7c variant 1513-WPRE plasmid DNA. Synapsin-driven jGCaMP7c expression. jGCaMP7c exhibits high contrast between peak fluorescence and resting fluorescence. It is useful for activity imaging of large populations of densely-labeled neurons because background fluorescence from inactive neurons is reduced. These AAV preparations are suitable purity for injection into animals.
    Promoter
    Syn
    Available Since
    July 12, 2019
    Availability
    Academic Institutions and Nonprofits only
  5. pGP-AAV-syn-FLEX-jGCaMP7b-WPRE (AAV Retrograde)

    Viral Prep
    #104493-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pGP-AAV-syn-FLEX-jGCaMP7b-WPRE (#104493). In addition to the viral particles, you will also receive purified pGP-AAV-syn-FLEX-jGCaMP7b-WPRE plasmid DNA. Synapsin-driven, Cre-dependent jGCaMP7b expression. jGCaMP7b expression exhibits the brightest resting fluorescence and can be used for imaging of small neuronal processes (dendrites and axons). These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Promoter
    Syn
    Available Since
    Nov. 14, 2019
    Availability
    Academic Institutions and Nonprofits only
Showing: 1801 - 1820 of 21505 results